Md. Code Regs. 10.28.11.02

Current through Register Vol. 51, No. 22, November 1, 2024

Section 10.28.11.02 - Diagnostic Pharmaceutical Agents

A. An optometrist certified by the Board as qualified to administer diagnostic pharmaceutical agents may use the following agents:

(1) Agents directly or indirectly affecting the pupil of the eye, including, but not limited to, the mydriatics and cycloplegics listed below:

(a) Phenylephrine hydrochloride (2.5 percent);

(b) Hydroxyamphetamine hydrobromide (1.0 percent);

(c) Cyclopentolate hydrochloride (0.5-2.0 percent);

(d) Tropicamide (0.5 and 1.0 percent);

(e) Cyclopentolate hydrochloride (0.2 percent) with phenylephrine hydrochloride (1.0 percent);

(f) Dapiprazole hydrochloride (0.5 percent);

(g) Hydroxyamphetamine hydrobromide (1.0 percent) and tropicamide (0.25 percent); and

(2) Agents directly or indirectly affecting the sensitivity of the cornea, including, but not limited to, the:

(a) Topical anesthetics listed below:

(i) Proparacaine hydrochloride (0.5 percent); and

(ii) Tetracaine hydrochloride (0.5 percent);

(b) Diagnostic topical anesthetic and dye combinations listed below:

(i) Benoxinate hydrochloride (0.4 percent)-fluorescein sodium (0.25 percent); and

(ii) Proparacaine hydrochloride (0.5 percent)-fluorescein sodium (0.25 percent).

B. The optometrist may use the diagnostic pharmaceutical agents listed in §A of this regulation in strengths not greater than the strengths indicated unless clinically indicated.

C. The optometrist may not dispense diagnostic pharmaceutical agents to patients for self-administration.

Md. Code Regs. 10.28.11.02

Regulation .02 amended effective 44:15 Md. R. 760, eff. 7/31/2017